A myosin II ATPase inhibitor reduces force production, glucose transport, and phosphorylation of AMPK and TBC1D1 in electrically stimulated rat skeletal muscle
about
Regulation of glucose and glycogen metabolism during and after exerciseRac1--a novel regulator of contraction-stimulated glucose uptake in skeletal muscleContraction-stimulated glucose transport in muscle is controlled by AMPK and mechanical stress but not sarcoplasmatic reticulum Ca(2+) releaseStretch-stimulated glucose transport in skeletal muscle is regulated by Rac1In vivo exercise followed by in vitro contraction additively elevates subsequent insulin-stimulated glucose transport by rat skeletal muscle.Mechanisms for greater insulin-stimulated glucose uptake in normal and insulin-resistant skeletal muscle after acute exercise.Increased AS160 phosphorylation, but not TBC1D1 phosphorylation, with increased postexercise insulin sensitivity in rat skeletal muscle.Exercise and insulin: Convergence or divergence at AS160 and TBC1D1?Is contraction-stimulated glucose transport feedforward regulated by Ca2+?Generation of contractile actomyosin bundles depends on mechanosensitive actin filament assembly and disassembly.Contracting C2C12 myotubes release CCL2 in an NF-κB-dependent manner to induce monocyte chemoattraction.Contraction-related stimuli regulate GLUT4 traffic in C2C12-GLUT4myc skeletal muscle cells.Leucine modulates contraction- and insulin-stimulated glucose transport and upstream signaling events in rat skeletal muscle.Role of reactive oxygen species in regulation of glucose transport in skeletal muscle during exercise.Ca²⁺ signals promote GLUT4 exocytosis and reduce its endocytosis in muscle cells.
P2860
Q24599638-E2D832D1-47C3-4069-BB7F-7FCA9EC8FFE6Q28248349-2CBFAAA5-9942-4C97-B52E-8AB90436FC1CQ28250541-F442FDA7-C523-4716-9F02-D7FD1DA56F8BQ28251973-36BEB428-10C6-461C-92E0-C62DE580DC9EQ33840346-F651DA27-55D3-4A37-9639-547F9F37EDEEQ36751833-552E7B65-38CB-4816-A433-0C800CF667CEQ37264161-92421BE1-1F09-4F82-A557-2D71DC3EB64BQ37461645-28673E65-DBE4-477D-9219-E640C84C74A0Q38244798-35042C65-280F-49E6-83E9-0280ADC34137Q38813076-B0491AA3-000A-49C6-B3B4-078ACB4918D4Q38820507-E7D105FA-475A-4A18-A974-81220F08BAA4Q39738829-80DF67D9-1B7D-4F7F-ACD7-7F601C111829Q43235353-6ECF0F15-48D2-417F-A1DD-55190A43D071Q46607653-6B4665FB-FF1A-4E13-A69F-8E4D18BCBFD3Q54347614-C7FD7608-998C-4121-9A00-9B86584DDD8C
P2860
A myosin II ATPase inhibitor reduces force production, glucose transport, and phosphorylation of AMPK and TBC1D1 in electrically stimulated rat skeletal muscle
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A myosin II ATPase inhibitor r ...... stimulated rat skeletal muscle
@en
A myosin II ATPase inhibitor r ...... timulated rat skeletal muscle.
@nl
type
label
A myosin II ATPase inhibitor r ...... stimulated rat skeletal muscle
@en
A myosin II ATPase inhibitor r ...... timulated rat skeletal muscle.
@nl
prefLabel
A myosin II ATPase inhibitor r ...... stimulated rat skeletal muscle
@en
A myosin II ATPase inhibitor r ...... timulated rat skeletal muscle.
@nl
P2093
P2860
P921
P1476
A myosin II ATPase inhibitor r ...... stimulated rat skeletal muscle
@en
P2093
David R Blair
George G Schweitzer
Katsuhiko Funai
P2860
P304
E993-E1002
P356
10.1152/AJPENDO.91003.2008
P577
2009-02-03T00:00:00Z